Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain

The emergence of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the etiological agent of the 2019 coronavirus disease (COVID-19), has erupted into a global pandemic that has led to tens of millions of infections and hundreds of thousands of deaths worldwide. The development of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Outlaw, Victor K., Bovier, Francesca T., Mears, Megan C., Cajimat, Maria N., Zhu, Yun, Lin, Michelle J., Addetia, Amin, Lieberman, Nicole A. P., Peddu, Vikas, Xie, Xuping, Shi, Pei-Yong, Greninger, Alexander L., Gellman, Samuel H., Bente, Dennis A., Moscona, Anne, Porotto, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587434/
https://www.ncbi.nlm.nih.gov/pubmed/33082259
http://dx.doi.org/10.1128/mBio.01935-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587434/
https://www.ncbi.nlm.nih.gov/pubmed/33082259
http://dx.doi.org/10.1128/mBio.01935-20

Ejemplares similares